How do you choose chemotherapy for a pediatric patient with mixed-phenotype acute leukemia?

I would begin treatment with a high risk ALL regimen and monitor response closely. While there is not a standard regimen for the treatment of MPAL, in several retrospective analyses, rates of remission and outcomes have been shown to be superior with initial ALL vs. AML or hybrid (both ALL and AML) ...